好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ongoing Safety and Effectiveness: An Interim Analysis of Long-Term Fingolimod Treatment
Multiple Sclerosis
(-)
057
Authors/Disclosures
Jeffrey A. Cohen, MD (Cleveland Clinic)
PRESENTER
Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Ashish Pradhan, MD (Genentech) Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
No disclosure on file
Rebecca Gottschalk (Novartis Pharmaceuticals) No disclosure on file
Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) Dr. Kappos has nothing to disclose.